These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 23942292)

  • 1. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
    Ferreri AJ; Govi S; Ponzoni M
    Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of radiotherapy in the treatment of lymphomas of the gastrointestinal tract.
    Aleman BM; Haas RL; van der Maazen RW
    Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):27-34. PubMed ID: 20206106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
    Kuo SH; Cheng AL
    Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma.
    Iwano M; Watanabe N; Matsushima Y; Seno H; Oki K; Sakurai T; Inagaki H; Okazaki K; Chiba T
    Am J Gastroenterol; 2006 Dec; 101(12):2878-83. PubMed ID: 17026570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of gastric marginal zone lymphoma of MALT type.
    Stathis A; Bertoni F; Zucca E
    Expert Opin Pharmacother; 2010 Sep; 11(13):2141-52. PubMed ID: 20586708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication.
    Tari A; Asaoku H; Kashiwado K; Yoshino T; Kitadai Y; Tanaka S; Fujihara M
    Dig Endosc; 2009 Oct; 21(4):219-27. PubMed ID: 19961519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of gastric lymphoma after stomach conserving treatment.
    Fischbach W
    Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):71-7. PubMed ID: 20206110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The gastric MALT lymphoma. An unforeseen model for studying the pathogenesis of the lymphomas].
    Savio A
    Recenti Prog Med; 2009 Jun; 100(6):311-21. PubMed ID: 19708303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
    Montalban C; Santon A; Boixeda D; Bellas C
    Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas.
    W√ľndisch T; Kim TD; Thiede C; Morgner A; Alpen B; Stolte M; Neubauer A
    Ann Hematol; 2003 Sep; 82(9):535-45. PubMed ID: 12845479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication in gastric diffuse large B cell lymphoma.
    Paydas S
    World J Gastroenterol; 2015 Apr; 21(13):3773-6. PubMed ID: 25852262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
    Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
    Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.